Central Nervous System Agents in Medicinal Chemistry
Title:ACKNOWLEDGEMENTS TO REVIEWERS
Volume: 16 Issue: 3
Export Options
About this article
Cite this article as:
ACKNOWLEDGEMENTS TO REVIEWERS, Central Nervous System Agents in Medicinal Chemistry 2016; 16 (3) . https://dx.doi.org/10.2174/187152491603161006123040
DOI https://dx.doi.org/10.2174/187152491603161006123040 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
18
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Uridine Function in the Central Nervous System
Current Topics in Medicinal Chemistry Fundamental, Electron Transfer Mechanism by Pyrylium-Type Ions for the Anticancer Drugs 5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA) and Flavone-8-Acetic Acid (FAA)
Current Medicinal Chemistry - Anti-Cancer Agents Efficient Purification of rhG-CSF and its PEGylated Forms and Evaluation for In Vitro Activities
Protein & Peptide Letters Molecular Predictors of Drug-induced Prolongation of the QT Interval
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Neuroprotection Abilities of Cytosolic Phospholipase A2 Inhibitors in Kainic acid-induced Neurodegeneration
Current Drug Targets - Cardiovascular & Hematological Disorders Developmental Immunotoxicity (DIT) in Drug Safety Testing: Matching DIT Testing to Adverse Outcomes and Childhood Disease Risk
Current Drug Safety Functional Consequences of Locus Coeruleus Degeneration in Alzheimers Disease
Current Alzheimer Research Applications of Lipid based Formulation Technologies in the Delivery of Biotechnology-based Therapeutics
Current Pharmaceutical Biotechnology Rehabilitation of Schizophrenic Patients
Current Pharmaceutical Design Editorial: Medical Science Beyond Formal Institutional Boundaries
Inflammation & Allergy - Drug Targets (Discontinued) The Role of Coagulation in Pulmonary Pathology
Inflammation & Allergy - Drug Targets (Discontinued) Regulation of the Urokinase Receptor (uPAR) by LDL Receptor-related Protein-1 (LRP1)
Current Pharmaceutical Design Lessons from Seven Decades of Antituberculosis Drug Discovery
Current Topics in Medicinal Chemistry Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors
Current Drug Targets Polyphenols: A Potential New Strategy for the Prevention and Treatment of Anxiety and Depression
Current Nutrition & Food Science Melatonin Causes Gene Expression in Aged Animals to Respond to Inflammatory Stimuli in a Manner Differing from that of Young Animals
Current Aging Science Network Pharmacology Analysis on Zhichan Powder in the Treatment of Parkinson's Disease
Combinatorial Chemistry & High Throughput Screening Relationship Between Gyrification and Functional Connectivity of the Prefrontal Cortex in Subjects at High Genetic Risk of Schizophrenia
Current Pharmaceutical Design Synthesis and Characterization of New Galanthamine Derivatives Comprising Peptide Moiety
Protein & Peptide Letters Subject Index to Volume 10
Current Pharmaceutical Design